Industry / Switzerland
If you would like to subscribe to Western Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Western Europe Pharma & Healthcare Insight please click on the trial link below.
Innovative Drugs Drive Market
March 2008 | Industry NewsSorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Western Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Western Europe Pharma & Healthcare Insight please click on the trial link below.
BMI has revised its forecasts for the Swiss drug market after new figures were released by IMS Health. We now expect drug spending to reach US$5.56bn in 2012, representing a compound annual growth rate (CAGR) of 4.6%.